Official Statements and Press Releases

CLL patient, Rep. DeSaulnier’s condition worsens, now listed as critical in the hospital

Representative Mark DeSaulnier fell when running and was admitted to hospital on March 13, 2020 with a fractured rib and... Details

CLL Society Special Alert – March 13, 2020

The COVID-19 (Coronavirus 19) is potentially very dangerous to CLL patients. Most CLL patients already fall into the higher risk... Details

When you say coronavirus will only kill the vulnerable, you’re talking about me

Here is an opinion piece from one of the 9 million immunocompromised patients living in the USA. I am sure we... Details

Updated every minute, 17-year-old whiz kid’s coronavirus site used by millions

Not much good news, but this young man from Seattle is trying to help through his website. A self-taught computer... Details

WHAT’S IN A NAME: The Coronavirus Pandemic

Let’s talk words. They don’t mean much in this context. As the Bard said: “A rose by any other name would... Details

COVID-19 (March 7, 2020)

We are receiving many requests to suggest any special precautions for us, CLL patients, in response to the spreading risk... Details

2019 Novel Coronavirus, or 2019-nCoV: What’s the risk?

2019 Novel Coronavirus, or 2019-nCoV: What's the risk? Many of us are worried by news of the novel coronavirus, 2019-nCoV in... Details

CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference

CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference CLL Society co-founder and Medical Director... Details

U.S. Food and Drug Administration (FDA) Approves Acalabrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

For immediate release, Nov 21. 2019 U.S. Food and Drug Administration (FDA) Approves Acalabrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) On... Details